AIDS Treatment Data Network
611
Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
| The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org) |
Novartis
Patient Assistance Program
Products covered:
Famvir (famciclovir)
Lamisil (terbinafine)
Lamprene (clofazamine)
Sandimmune (cyclosporine)
Sandostatin (octreotide acetate)
Tegretol (carbamazepine)
| Contact | 1-800-277-2254
www.pharma.us.novartis.com/novartis/pap/pap.jsp
|
|
| Program Eligibility |
The patient must meet the following criteria to qualify:
- Must be a U.S. Resident.
- Has no health insurance or prescription coverage.
- Not eligible for Medicaid, ADAP, or other drug assistance programs.
- Income eligiblity evaluated on a case-by-case basis. Must provide proof of income.
|
| Enrollment Process |
Patients and doctors can call to get an application form faxed or mailed to them. Once accepted, a refill mailer must be send in every 90 days.
|
|
| Re-Application |
Annual re-application is needed.
|
|
| Comments |
It will take 2-3 weeks for the application to be reviewed. Once accepted drug is shipped out on 3-day priority mail.
|
|